HeartBeam, Inc. (NASDAQ: BEAT) Stock Competitors & Peer Comparison
See BEAT's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Specialties Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for BEAT and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BEAT | $0.45 | +4.33% | 24.7M | -0.87 | -$0.51 | N/A |
| ALC | $69.12 | -1.96% | 33.7B | 21.74 | $3.18 | +0.52% |
| STE | $218.44 | -2.74% | 21.3B | 20.98 | $10.42 | +1.18% |
| QDEL | $13.38 | -4.22% | 912.4M | 9.99 | $1.34 | N/A |
| MLAB | $123.74 | -3.16% | 692.4M | 12.49 | $9.91 | +0.51% |
| BWAY | $14.16 | +0.07% | 555.4M | 35.97 | $0.39 | N/A |
| SI | $19.99 | -1.62% | 415M | -10.45 | -$1.91 | N/A |
| MASS | $9.81 | -2.39% | 402.5M | -16.35 | -$0.60 | N/A |
| MOBI | $11.09 | -4.64% | 368.7M | -0.59 | -$18.78 | N/A |
| ANIK | $21.04 | +1.11% | 281.6M | 42.94 | $0.49 | N/A |
Stock Comparison
Alcon Inc. (NYSE: ALC)
BEAT vs ALC Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEAT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEAT stands at 24.7M. In comparison, ALC has a market cap of 33.7B. Regarding current trading prices, BEAT is priced at $0.45 on the NASDAQ, while ALC trades at $69.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEAT currently has a P/E ratio of -0.87, whereas ALC's P/E ratio is 21.74. In terms of profitability, BEAT's ROE is -6.87%, compared to ALC's ROE of +0.03%. Regarding short-term risk, BEAT is more volatile compared to ALC. This indicates higher risk in terms of short-term price fluctuations for BEAT.Check ALC's competition here
STERIS plc (NYSE: STE)
BEAT vs STE Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEAT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEAT stands at 24.7M. In comparison, STE has a market cap of 21.3B. Regarding current trading prices, BEAT is priced at $0.45 on the NASDAQ, while STE trades at $218.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEAT currently has a P/E ratio of -0.87, whereas STE's P/E ratio is 20.98. In terms of profitability, BEAT's ROE is -6.87%, compared to STE's ROE of +0.11%. Regarding short-term risk, BEAT is more volatile compared to STE. This indicates higher risk in terms of short-term price fluctuations for BEAT.Check STE's competition here
QuidelOrtho Corporation (NASDAQ: QDEL)
BEAT vs QDEL Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEAT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEAT stands at 24.7M. In comparison, QDEL has a market cap of 912.4M. Regarding current trading prices, BEAT is priced at $0.45 on the NASDAQ, while QDEL trades at $13.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEAT currently has a P/E ratio of -0.87, whereas QDEL's P/E ratio is 9.99. In terms of profitability, BEAT's ROE is -6.87%, compared to QDEL's ROE of -0.55%. Regarding short-term risk, BEAT is less volatile compared to QDEL. This indicates lower risk in terms of short-term price fluctuations for BEAT.Check QDEL's competition here
Mesa Laboratories, Inc. (NASDAQ: MLAB)
BEAT vs MLAB Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEAT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEAT stands at 24.7M. In comparison, MLAB has a market cap of 692.4M. Regarding current trading prices, BEAT is priced at $0.45 on the NASDAQ, while MLAB trades at $123.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEAT currently has a P/E ratio of -0.87, whereas MLAB's P/E ratio is 12.49. In terms of profitability, BEAT's ROE is -6.87%, compared to MLAB's ROE of +0.03%. Regarding short-term risk, BEAT is more volatile compared to MLAB. This indicates higher risk in terms of short-term price fluctuations for BEAT.Check MLAB's competition here
BrainsWay Ltd. (NASDAQ: BWAY)
BEAT vs BWAY Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEAT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEAT stands at 24.7M. In comparison, BWAY has a market cap of 555.4M. Regarding current trading prices, BEAT is priced at $0.45 on the NASDAQ, while BWAY trades at $14.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEAT currently has a P/E ratio of -0.87, whereas BWAY's P/E ratio is 35.97. In terms of profitability, BEAT's ROE is -6.87%, compared to BWAY's ROE of +0.13%. Regarding short-term risk, BEAT is more volatile compared to BWAY. This indicates higher risk in terms of short-term price fluctuations for BEAT.Check BWAY's competition here
Shoulder Innovations, Inc. (NYSE: SI)
BEAT vs SI Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEAT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEAT stands at 24.7M. In comparison, SI has a market cap of 415M. Regarding current trading prices, BEAT is priced at $0.45 on the NASDAQ, while SI trades at $19.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEAT currently has a P/E ratio of -0.87, whereas SI's P/E ratio is -10.45. In terms of profitability, BEAT's ROE is -6.87%, compared to SI's ROE of -0.26%. Regarding short-term risk, BEAT is more volatile compared to SI. This indicates higher risk in terms of short-term price fluctuations for BEAT.Check SI's competition here
908 Devices Inc. (NASDAQ: MASS)
BEAT vs MASS Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEAT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEAT stands at 24.7M. In comparison, MASS has a market cap of 402.5M. Regarding current trading prices, BEAT is priced at $0.45 on the NASDAQ, while MASS trades at $9.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEAT currently has a P/E ratio of -0.87, whereas MASS's P/E ratio is -16.35. In terms of profitability, BEAT's ROE is -6.87%, compared to MASS's ROE of -0.25%. Regarding short-term risk, BEAT is more volatile compared to MASS. This indicates higher risk in terms of short-term price fluctuations for BEAT.Check MASS's competition here
Mobia Medical, Inc. Common Stock (NASDAQ: MOBI)
BEAT vs MOBI Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEAT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEAT stands at 24.7M. In comparison, MOBI has a market cap of 368.7M. Regarding current trading prices, BEAT is priced at $0.45 on the NASDAQ, while MOBI trades at $11.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEAT currently has a P/E ratio of -0.87, whereas MOBI's P/E ratio is -0.59. In terms of profitability, BEAT's ROE is -6.87%, compared to MOBI's ROE of -15.96%. Regarding short-term risk, BEAT is less volatile compared to MOBI. This indicates lower risk in terms of short-term price fluctuations for BEAT.Check MOBI's competition here
Anika Therapeutics, Inc. (NASDAQ: ANIK)
BEAT vs ANIK Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEAT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEAT stands at 24.7M. In comparison, ANIK has a market cap of 281.6M. Regarding current trading prices, BEAT is priced at $0.45 on the NASDAQ, while ANIK trades at $21.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEAT currently has a P/E ratio of -0.87, whereas ANIK's P/E ratio is 42.94. In terms of profitability, BEAT's ROE is -6.87%, compared to ANIK's ROE of -0.03%. Regarding short-term risk, BEAT is less volatile compared to ANIK. This indicates lower risk in terms of short-term price fluctuations for BEAT.Check ANIK's competition here
Standard BioTools Inc. (NASDAQ: LAB)
BEAT vs LAB Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEAT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEAT stands at 24.7M. In comparison, LAB has a market cap of 270.9M. Regarding current trading prices, BEAT is priced at $0.45 on the NASDAQ, while LAB trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEAT currently has a P/E ratio of -0.87, whereas LAB's P/E ratio is -9.89. In terms of profitability, BEAT's ROE is -6.87%, compared to LAB's ROE of -0.18%. Regarding short-term risk, BEAT is less volatile compared to LAB. This indicates lower risk in terms of short-term price fluctuations for BEAT.Check LAB's competition here
Trinity Biotech plc (NASDAQ: TRIB)
BEAT vs TRIB Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEAT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEAT stands at 24.7M. In comparison, TRIB has a market cap of 184.7M. Regarding current trading prices, BEAT is priced at $0.45 on the NASDAQ, while TRIB trades at $9.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEAT currently has a P/E ratio of -0.87, whereas TRIB's P/E ratio is -0.15. In terms of profitability, BEAT's ROE is -6.87%, compared to TRIB's ROE of +0.68%. Regarding short-term risk, BEAT is less volatile compared to TRIB. This indicates lower risk in terms of short-term price fluctuations for BEAT.Check TRIB's competition here
Edap Tms S.a. (NASDAQ: EDAP)
BEAT vs EDAP Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEAT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEAT stands at 24.7M. In comparison, EDAP has a market cap of 178.2M. Regarding current trading prices, BEAT is priced at $0.45 on the NASDAQ, while EDAP trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEAT currently has a P/E ratio of -0.87, whereas EDAP's P/E ratio is -5.80. In terms of profitability, BEAT's ROE is -6.87%, compared to EDAP's ROE of -3.13%. Regarding short-term risk, BEAT is less volatile compared to EDAP. This indicates lower risk in terms of short-term price fluctuations for BEAT.Check EDAP's competition here
Nyxoah S.A. (NASDAQ: NYXH)
BEAT vs NYXH Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEAT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEAT stands at 24.7M. In comparison, NYXH has a market cap of 162.1M. Regarding current trading prices, BEAT is priced at $0.45 on the NASDAQ, while NYXH trades at $1.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEAT currently has a P/E ratio of -0.87, whereas NYXH's P/E ratio is -0.64. In terms of profitability, BEAT's ROE is -6.87%, compared to NYXH's ROE of -1.80%. Regarding short-term risk, BEAT is less volatile compared to NYXH. This indicates lower risk in terms of short-term price fluctuations for BEAT.Check NYXH's competition here
Apyx Medical Corporation (NASDAQ: APYX)
BEAT vs APYX Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEAT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEAT stands at 24.7M. In comparison, APYX has a market cap of 128.4M. Regarding current trading prices, BEAT is priced at $0.45 on the NASDAQ, while APYX trades at $3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEAT currently has a P/E ratio of -0.87, whereas APYX's P/E ratio is -15.25. In terms of profitability, BEAT's ROE is -6.87%, compared to APYX's ROE of -0.79%. Regarding short-term risk, BEAT is more volatile compared to APYX. This indicates higher risk in terms of short-term price fluctuations for BEAT.Check APYX's competition here
SkinHealth Systems Inc. (NASDAQ: SKIN)
BEAT vs SKIN Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEAT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEAT stands at 24.7M. In comparison, SKIN has a market cap of 95.5M. Regarding current trading prices, BEAT is priced at $0.45 on the NASDAQ, while SKIN trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEAT currently has a P/E ratio of -0.87, whereas SKIN's P/E ratio is -3.35. In terms of profitability, BEAT's ROE is -6.87%, compared to SKIN's ROE of -0.48%. Regarding short-term risk, BEAT is less volatile compared to SKIN. This indicates lower risk in terms of short-term price fluctuations for BEAT.Check SKIN's competition here
DarioHealth Corp. (NASDAQ: DRIO)
BEAT vs DRIO Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEAT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEAT stands at 24.7M. In comparison, DRIO has a market cap of 51.4M. Regarding current trading prices, BEAT is priced at $0.45 on the NASDAQ, while DRIO trades at $7.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEAT currently has a P/E ratio of -0.87, whereas DRIO's P/E ratio is -1.20. In terms of profitability, BEAT's ROE is -6.87%, compared to DRIO's ROE of +1.04%. Regarding short-term risk, BEAT is less volatile compared to DRIO. This indicates lower risk in terms of short-term price fluctuations for BEAT.Check DRIO's competition here
Spectral AI, Inc. (NASDAQ: MDAI)
BEAT vs MDAI Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEAT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEAT stands at 24.7M. In comparison, MDAI has a market cap of 51.2M. Regarding current trading prices, BEAT is priced at $0.45 on the NASDAQ, while MDAI trades at $1.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEAT currently has a P/E ratio of -0.87, whereas MDAI's P/E ratio is -3.58. In terms of profitability, BEAT's ROE is -6.87%, compared to MDAI's ROE of +1.21%. Regarding short-term risk, BEAT is less volatile compared to MDAI. This indicates lower risk in terms of short-term price fluctuations for BEAT.Check MDAI's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
BEAT vs BEATW Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEAT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEAT stands at 24.7M. In comparison, BEATW has a market cap of 7.8M. Regarding current trading prices, BEAT is priced at $0.45 on the NASDAQ, while BEATW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEAT currently has a P/E ratio of -0.87, whereas BEATW's P/E ratio is -0.02. In terms of profitability, BEAT's ROE is -6.87%, compared to BEATW's ROE of -6.87%. Regarding short-term risk, BEAT is more volatile compared to BEATW. This indicates higher risk in terms of short-term price fluctuations for BEAT.Check BEATW's competition here
WORK Medical Technology Group Ltd. Class A (NASDAQ: WOK)
BEAT vs WOK Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEAT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEAT stands at 24.7M. In comparison, WOK has a market cap of 5M. Regarding current trading prices, BEAT is priced at $0.45 on the NASDAQ, while WOK trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEAT currently has a P/E ratio of -0.87, whereas WOK's P/E ratio is N/A. In terms of profitability, BEAT's ROE is -6.87%, compared to WOK's ROE of -0.19%. Regarding short-term risk, BEAT is less volatile compared to WOK. This indicates lower risk in terms of short-term price fluctuations for BEAT.Check WOK's competition here
QTREX Quantum Ltd. Warrant (NASDAQ: QTEXW)
BEAT vs QTEXW Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEAT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEAT stands at 24.7M. In comparison, QTEXW has a market cap of 3.5M. Regarding current trading prices, BEAT is priced at $0.45 on the NASDAQ, while QTEXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEAT currently has a P/E ratio of -0.87, whereas QTEXW's P/E ratio is -0.01. In terms of profitability, BEAT's ROE is -6.87%, compared to QTEXW's ROE of N/A. Regarding short-term risk, BEAT is less volatile compared to QTEXW. This indicates lower risk in terms of short-term price fluctuations for BEAT.Check QTEXW's competition here
ENvue Medical, Inc. (NASDAQ: FEED)
BEAT vs FEED Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEAT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEAT stands at 24.7M. In comparison, FEED has a market cap of 3.3M. Regarding current trading prices, BEAT is priced at $0.45 on the NASDAQ, while FEED trades at $4.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEAT currently has a P/E ratio of -0.87, whereas FEED's P/E ratio is -0.03. In terms of profitability, BEAT's ROE is -6.87%, compared to FEED's ROE of -0.60%. Regarding short-term risk, BEAT is less volatile compared to FEED. This indicates lower risk in terms of short-term price fluctuations for BEAT.Check FEED's competition here
iTonic Holdings Ltd. (NASDAQ: ITOC)
BEAT vs ITOC Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEAT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEAT stands at 24.7M. In comparison, ITOC has a market cap of 2.9M. Regarding current trading prices, BEAT is priced at $0.45 on the NASDAQ, while ITOC trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEAT currently has a P/E ratio of -0.87, whereas ITOC's P/E ratio is -0.99. In terms of profitability, BEAT's ROE is -6.87%, compared to ITOC's ROE of -0.94%. Regarding short-term risk, BEAT is less volatile compared to ITOC. This indicates lower risk in terms of short-term price fluctuations for BEAT.Check ITOC's competition here
Tivic Health Systems, Inc. (NASDAQ: TIVC)
BEAT vs TIVC Comparison September 2026
HeartBeam, Inc. (NASDAQ: BEAT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BEAT stands at 24.7M. In comparison, TIVC has a market cap of 279.2K. Regarding current trading prices, BEAT is priced at $0.45 on the NASDAQ, while TIVC trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BEAT currently has a P/E ratio of -0.87, whereas TIVC's P/E ratio is -0.04. In terms of profitability, BEAT's ROE is -6.87%, compared to TIVC's ROE of -1.65%. Regarding short-term risk, BEAT is less volatile compared to TIVC. This indicates lower risk in terms of short-term price fluctuations for BEAT.Check TIVC's competition here